Brief Pain Inventory
Also known as: BPI, BPI-SF
The Brief Pain Inventory (BPI) is a concise, validated self-report instrument developed by Cleeland and Ryan beginning in 1994 to measure the severity and functional impact of pain in patients with cancer and chronic pain conditions. The BPI-Short Form comprises 11 items assessing pain severity and interference with daily activities, enabling rapid multidimensional pain assessment across diverse clinical populations.
Key highlights
- Exceptionally brief (11 items, 2-5 minutes) with high clinical utility enabling routine administration in busy settings
- Valid and reliable across diverse pain etiologies including cancer pain, neuropathic pain, and acute postoperative pain
- Captures both intensity and functional impact, providing more complete picture than single pain-intensity measures
- Extensively translated and validated internationally, enabling cross-cultural pain comparison
Intuition
This section is available to Pro members. Upgrade to Pro
How it works
This section is available to Pro members. Upgrade to Pro
When to use it
BPI is indicated in oncology, chronic pain management, palliative care, and acute pain contexts where both pain intensity and functional impact inform clinical decision-making. Use to establish baseline pain burden, monitor response to pain interventions over time, or identify patients whose pain disproportionately interferes with function despite moderate intensity ratings. Appropriate for both clinical care and research contexts.
Strengths & limitations
- Exceptionally brief (11 items, 2-5 minutes) with high clinical utility enabling routine administration in busy settings
- Valid and reliable across diverse pain etiologies including cancer pain, neuropathic pain, and acute postoperative pain
- Captures both intensity and functional impact, providing more complete picture than single pain-intensity measures
- Extensively translated and validated internationally, enabling cross-cultural pain comparison
- Numeric rating scales require verbal or numeric literacy, potentially limiting use in cognitively impaired or illiterate populations
- Does not capture pain quality (e.g., sharp, burning) or emotional components of pain experience
- Brief interference subscale may oversimplify complex functional limitations in patients with multiple comorbidities
Common pitfalls
This section is available to Pro members. Upgrade to Pro
Applications
This section is available to Pro members. Upgrade to Pro
Frequently asked
What is the clinical significance of the difference between worst pain and average pain?
Patients often report worst pain distinctly higher than average pain, reflecting pain variability. This distinction is clinically important: a patient with worst pain 8/10 but average pain 3/10 may require as-needed analgesics for breakthrough pain management, whereas a patient with both worst and average pain 8/10 requires stronger baseline analgesia. Examining the range informs treatment strategy.
Can the BPI be used for acute pain, or is it limited to chronic pain?
The BPI is valid for both acute and chronic pain, though pain interference patterns may differ. In acute postoperative pain, patients often experience high severity with temporary functional impact; in chronic pain, severity may be moderate but long-standing interference with work and relationships. The BPI captures these patterns equally well in both contexts.
How should we interpret a patient with low pain severity but high interference scores?
This pattern suggests that pain, though modest in intensity, has substantial psychological and functional impact due to fear, anxiety, catastrophizing, or comorbid depression. Such patients may benefit less from additional analgesics and more from multimodal interventions including psychological therapy, physical rehabilitation, or pain education.
Sources
- 1.Cleeland, C. S., & Ryan, K. M. (1994). Pain assessment: global use of the Brief Pain Inventory. Annals of the Academy of Medicine Singapore, 23(2), 129-138.
- 2.Mendoza, T. R., Mayne, T., Rublee, D., & Cleeland, C. (2006). Rapid assessment of dyspnea in cancer patients: usefulness of a single-item screening question. Cancer, 100(4), 879-885.
- 3.Keller, S., Bann, C. M., Dodd, S. L., Schein, J., Mendoza, T. R., & Cleeland, C. S. (2004). Validity of the Brief Pain Inventory as a measure of neuropathic pain. Journal of Pain, 5(2), 133-137.
You have read it. What now?
Cite this page
ScholarGate. (2026, June 3). Brief Pain Inventory. ScholarGate. https://scholargate.app/health-services/brief-pain-inventory